Patients with ALS/FTD due to ANXA11 mutations develop hallmark pathological features of TDP‐43 mislocalization, including its loss in the nucleus and aggregation in the cytoplasm.8, 36. The gene discussed is ANXA11; the disease is amyotrophic lateral sclerosis.